Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. 22 de may. de 2024 · Glucophage (or the generic name metformin HCL) is one of the most common diabetes medications drugs that a doctor will prescribe to a new diabetic. Glucophage is an oral form of metformin to reduce high blood glucose levels.

  2. en.wikipedia.org › wiki › MetforminMetformin - Wikipedia

    Hace 2 días · Metformin, sold under the brand name Glucophage, among others, is the main first-line medication for the treatment of type 2 diabetes, particularly in people who are overweight. It is also used in the treatment of polycystic ovary syndrome.

  3. 14 de may. de 2024 · Several classes of diabetes medicines offer different mechanisms of action and benefits for managing type 2 diabetes. These alternatives may be more suitable for people who cannot tolerate metformin or find it ineffective.

  4. 20 de may. de 2024 · These combination drugs, which include pairings with empagliflozin (brand names Synjardy and Synjardy XR), dapagliflozin (Xigduo XR), and ertugliflozin (Segluromet), work by helping the kidneys to excrete more glucose through the urine, which reduces overall blood glucose levels.

  5. 10 de may. de 2024 · ACP recommends against adding a dipeptidyl peptidase-4 (DPP-4) inhibitor to metformin and lifestyle modifications in adults with type 2 diabetes and inadequate glycemic control to reduce morbidity and all-cause mortality (strong recommendation; high-certainty evidence).

  6. 8 de may. de 2024 · Ozempic is a once-weekly injection approved to treat Type 2 diabetes in adults. It can also lower the risk of major adverse cardiovascular events (heart attack, stroke, or cardiovascular death) if you have both diabetes and heart disease.

  7. 20 de may. de 2024 · Mounjaro is an FDA-approved medicine used to improve blood sugar (glucose) levels in adults with type 2 diabetes mellitus when used together with diet and exercise. Mounjaro’s active ingredient tirzepatide was used in the Phase 3 SURMOUNT-1 72-week weight loss clinical trials.